SynCardia's profile can be viewed at http://www.forbes.com/companies/syncardia-systems/
CAUTION – The Freedom® portable driver is an investigational device, limited by United States law to investigational use.
Like SynCardia on Facebook -
Follow SynCardia on Twitter –
About the SynCardia temporary Total Artificial Heart
SynCardia Systems, Inc. (
) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, SynCardia's Total Artificial Heart is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. There have been more than 1,100 implants of the Total Artificial Heart, accounting for more than 290 patient years of life.
Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at
SynCardia Certified Centers
. It is the only device that provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.
SynCardia Wins Two Gold Stevies® at 2012 American Business Awards
June 18, 2012
, SynCardia was honored with two Gold Stevie® Awards at the
10th Annual American Business Awards
. SynCardia won "Company of the Year – Health Products and Services" and "Most Innovative Company of the Year – up to 100 Employees." See the full list of
SynCardia Awards & Recognition
, which includes accolades from Forbes, Fast Company and more.
SOURCE SynCardia Systems, Inc.